Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT02454270
Title A Dose Escalation Study of JNJ-64052781 in Participants With Relapsed or Refractory B-cell Malignancies
Recruitment Terminated
Gender both
Phase Phase II
Variant Requirements No
Sponsors Janssen Research & Development, LLC
Age Groups: adult
Covered Countries USA | FRA | ESP | BEL

No variant requirements are available.